XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.4195
-0.0105 (-2.44%)
At close: Feb 10, 2026, 4:00 PM EST
0.4286
+0.0091 (2.17%)
After-hours: Feb 10, 2026, 7:45 PM EST
XORTX Therapeutics Employees
As of December 31, 2023, XORTX Therapeutics had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$647,769
Market Cap
2.98M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2023 | 3 | 0 | - | 2 | 1 |
| Dec 31, 2022 | 3 | 0 | - | 3 | 0 |
| Jan 1, 2022 | 3 | - | - | 3 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 49 |
| HCW Biologics | 36 |
| Scinai Immunotherapeutics | 31 |
| Lyra Therapeutics | 30 |
| Enveric Biosciences | 6 |
| Artelo Biosciences | 5 |
| Oragenics | 5 |
| Adial Pharmaceuticals | 5 |
XRTX News
- 4 months ago - XORTX Announces Pricing of US$1.1 Million Registered Direct Offering - GlobeNewsWire
- 4 months ago - XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency - GlobeNewsWire
- 4 months ago - XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - GlobeNewsWire
- 4 months ago - XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems - GlobeNewsWire
- 5 months ago - XORTX Initiates IND Preparation for XORLO™ in Gout Program - GlobeNewsWire
- 6 months ago - XORTX Completes USD $114,500 Private Placement - GlobeNewsWire
- 7 months ago - XORTX Completes Non-Brokered Private Placement of Units - GlobeNewsWire
- 8 months ago - XORTX Announces USD $925,000 Private Placement - GlobeNewsWire